Parametrica Management’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-5,310
Closed -$388K 111
2018
Q1
$388K Sell
5,310
-651
-11% -$44.7K 0.48% 58
2017
Q4
$346K Sell
5,961
-1,887
-24% -$99.4K 0.22% 153
2017
Q3
$352K Buy
+7,848
New +$326K 0.15% 149

Other funds holding HAE

Parametrica Management's HAE Position: Q2 2018 in Review

Parametrica Management sold out of Haemonetics (HAE) in Q2 2018, closing a stake of 5,310 shares — an estimated $388K sold.

Parametrica Management first reported a position in HAE in Q3 2017 and held it in 3 quarters. The position peaked at $388K in Q1 2018. 293 funds tracked by Wall St. Rank hold HAE as of Q2 2018.

  • Parametrica Management reported no remaining Haemonetics position as of Q2 2018 after selling out during the quarter.
  • Parametrica Management sold 5,310 Haemonetics shares in Q2 2018, an estimated $388K.
  • Parametrica Management first reported a position in Haemonetics in Q3 2017 and held it in 3 quarters.
  • Parametrica Management's Haemonetics position peaked at $388K in Q1 2018.
  • 293 funds tracked by Wall St. Rank held Haemonetics as of Q2 2018.

Based on Parametrica Management's 13F filing for Q2 2018, filed 23 Jul 2018.